MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2024.1519415

Медицинская библиотека · Frontiers in immunology · 2024

Soluble factors released by peripheral blood-derived CAR-NK cells cause bystander myeloid cell activation.

Khanal Supreet, Baer Alan, Hossain Md Kamal, Colon-Moran Winston, Panthi Santosh, Bhattarai Nirjal

СтатьяПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

INTRODUCTION

CAR-T cell therapy is associated with life-threatening inflammatory toxicities, partly due to the activation and secretion of inflammatory cytokines by bystander myeloid cells (BMCs). However, due to limited clinical data, it is unclear whether CAR-NK cells cause similar toxicities.

METHODS

We characterized the soluble factors (SFs) released by activated human CAR-T and CAR-NK cells and assessed their role in BMC activation (BMCA).

RESULTS

We found that SFs from both activated, peripheral blood-derived CAR-T (PB-CAR-T) and CAR-NK (PB-CAR-NK) cells induced BMCA; however, PB-CAR-NK cells caused significantly lower BMCA compared to PB-CAR-T cells. Interestingly, SFs from cord-blood-derived (CB) NK cells caused little to no BMCA, consistent with previous clinical studies showing minimal inflammatory toxicity with CB-CAR-NK cells. Comparative analysis of SFs released by PB-NK and PB-CAR-NK cells following CAR-dependent and CAR-independent activation revealed several candidate factors with the potential to cause BMCA. Antibody-mediated neutralization studies identified a combination of four factors that contribute to PB-CAR-NK cell-mediated BMCA. siRNA-mediated knockdown studies confirmed that inactivating these four factors in PB-CAR-NK cells significantly reduces BMCA. Importantly, neutralization or knockdown of these four factors did not affect CAR-NK cell potency.

DISCUSSION: These data suggest that specific SFs released by PB-CAR-NK cells activate BMCs and have the potential to contribute to inflammatory toxicities. Furthermore, inactivation of these four factors in PB-CAR-NK cells could reduce inflammatory toxicities and improve safety of PB-CAR-NK cell therapy without compromising potency.

Для цитирования: Khanal Supreet, Baer Alan, Hossain Md Kamal, Colon-Moran Winston, Panthi Santosh, Bhattarai Nirjal. Soluble factors released by peripheral blood-derived CAR-NK cells cause bystander myeloid cell activation.. Frontiers in immunology. 2024. DOI: 10.3389/fimmu.2024.1519415.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.